{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:58:43Z","timestamp":1781780323036,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Naval Medical Center's Foundational Strengthening Initiative","award":["24QJJH18"],"award-info":[{"award-number":["24QJJH18"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-025-05974-5","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:03:59Z","timestamp":1769576639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ZDHHC4-mediated ZEB-2\u00a0S-palmitoylation promotes melanoma epithelial-mesenchymal transition via deubiquitinating and stabilizing ZEB-2"],"prefix":"10.1007","volume":"83","author":[{"given":"Shisong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxi","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1672-9835","authenticated-orcid":false,"given":"Ze","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"5974_CR1","doi-asserted-by":"crossref","unstructured":"Allouche J et al (2021) NNT mediates redox-dependent pigmentation via a UVB- and MITF-independent mechanism. Cell 184:4268\u20134283. e4220","DOI":"10.26226\/m.62fa00a494adc30018783ac9"},{"key":"5974_CR2","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nature05660","volume":"445","author":"JY Lin","year":"2007","unstructured":"Lin JY, Fisher DE (2007) Melanocyte biology and skin pigmentation. Nature 445:843\u2013850","journal-title":"Nature"},{"key":"5974_CR3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41568-023-00565-7","volume":"23","author":"PP Centeno","year":"2023","unstructured":"Centeno PP, Pavet V, Marais R (2023) The journey from melanocytes to melanoma. Nat Rev Cancer 23:372\u2013390","journal-title":"Nat Rev Cancer"},{"key":"5974_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","volume":"402","author":"GV Long","year":"2023","unstructured":"Long GV, Swetter SM, Menzies AM, Gershenwald JE, Scolyer RA (2023) Cutaneous melanoma. Lancet 402:485\u2013502","journal-title":"Lancet"},{"key":"5974_CR5","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jaad.2019.03.066","volume":"81","author":"ME DeWane","year":"2019","unstructured":"DeWane ME, Kelsey A, Oliviero M, Rabinovitz H, Grant-Kels JM (2019) Melanoma on chronically sun-damaged skin: lentigo maligna and desmoplastic melanoma. J Am Acad Dermatol 81:823\u2013833","journal-title":"J Am Acad Dermatol"},{"key":"5974_CR6","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1158\/2159-8290.CD-22-0603","volume":"12","author":"F Newell","year":"2022","unstructured":"Newell F et al (2022) Comparative genomics provides etiologic and biological insight into melanoma subtypes. Cancer Discov 12:2856\u20132879","journal-title":"Cancer Discov"},{"key":"5974_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0190-9622(90)70019-E","volume":"22","author":"VC Ho","year":"1990","unstructured":"Ho VC, Sober AJ (1990) Therapy for cutaneous melanoma: an update. J Am Acad Dermatol 22:159\u2013176","journal-title":"J Am Acad Dermatol"},{"key":"5974_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"Morton DL et al (2014) Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 370:599\u2013609","journal-title":"N Engl J Med"},{"key":"5974_CR9","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1200\/JCO.22.02575","volume":"41","author":"GV Long","year":"2023","unstructured":"Long GV, Menzies AM, Scolyer RA (2023) Neoadjuvant checkpoint immunotherapy and melanoma: the time is now. J Clin Oncol 41:3236\u20133248","journal-title":"J Clin Oncol"},{"key":"5974_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00827-6","volume":"6","author":"W Guo","year":"2021","unstructured":"Guo W, Wang H, Li C (2021) Signal pathways of melanoma and targeted therapy. Signal Transduct Target Ther 6:424","journal-title":"Signal Transduct Target Ther"},{"key":"5974_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jaci.2021.04.024","volume":"149","author":"M Lee","year":"2022","unstructured":"Lee M et al (2022) DEP-induced ZEB2 promotes nasal polyp formation via epithelial-to-mesenchymal transition. J Allergy Clin Immunol 149:340\u2013357","journal-title":"J Allergy Clin Immunol"},{"key":"5974_CR12","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/med.21948","volume":"43","author":"HL Ang","year":"2023","unstructured":"Ang HL et al (2023) Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds. Med Res Rev 43:1141\u20131200","journal-title":"Med Res Rev"},{"key":"5974_CR13","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1158\/0008-5472.CAN-19-2373","volume":"80","author":"N Vandamme","year":"2020","unstructured":"Vandamme N et al (2020) The EMT transcription factor ZEB2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype. Cancer Res 80:2983\u20132995","journal-title":"Cancer Res"},{"key":"5974_CR14","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/cdd.2014.44","volume":"21","author":"G Denecker","year":"2014","unstructured":"Denecker G et al (2014) Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression. Cell Death Differ 21:1250\u20131261","journal-title":"Cell Death Differ"},{"issue":"4","key":"5974_CR15","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ccr.2013.08.018","volume":"24","author":"J Caramel","year":"2013","unstructured":"Caramel J et al (2013) A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell 24(4):466\u2013480","journal-title":"Cancer Cell"},{"key":"5974_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.semcancer.2023.10.001","volume":"97","author":"M Saitoh","year":"2023","unstructured":"Saitoh M (2023) Transcriptional regulation of EMT transcription factors in cancer. Semin Cancer Biol 97:21\u201329","journal-title":"Semin Cancer Biol"},{"key":"5974_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153876","volume":"95","author":"SC Liu","year":"2022","unstructured":"Liu SC et al (2022) Attenuation of in vitro and in vivo melanin synthesis using a Chinese herbal medicine through the inhibition of tyrosinase activity. Phytomedicine 95:153876","journal-title":"Phytomedicine"},{"key":"5974_CR18","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1136\/gutjnl-2023-330826","volume":"73","author":"L Bu","year":"2024","unstructured":"Bu L et al (2024) High-fat diet promotes liver tumorigenesis via palmitoylation and activation of AKT. Gut 73:1156\u20131168","journal-title":"Gut"},{"key":"5974_CR19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI165510","author":"JG Ren","year":"2023","unstructured":"Ren JG et al (2023) RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI165510","journal-title":"J Clin Invest"},{"key":"5974_CR20","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1158\/2159-8290.CD-20-1571","volume":"11","author":"W Du","year":"2021","unstructured":"Du W et al (2021) Loss of optineurin drives cancer immune evasion via palmitoylation-dependent IFNGR1 lysosomal sorting and degradation. Cancer Discov 11:1826\u20131843","journal-title":"Cancer Discov"},{"key":"5974_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41551-019-0375-6","volume":"3","author":"H Yao","year":"2019","unstructured":"Yao H et al (2019) Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours. Nat Biomed Eng 3:306\u2013317","journal-title":"Nat Biomed Eng"},{"key":"5974_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18565-8","volume":"11","author":"JW Hao","year":"2020","unstructured":"Hao JW et al (2020) CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis. Nat Commun 11:4765","journal-title":"Nat Commun"},{"key":"5974_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature23887","volume":"549","author":"S Chen","year":"2017","unstructured":"Chen S et al (2017) Palmitoylation-dependent activation of MC1R prevents melanomagenesis. Nature 549:399\u2013403","journal-title":"Nature"},{"key":"5974_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33788-7","volume":"13","author":"H Guo","year":"2022","unstructured":"Guo H et al (2022) Targeting EGFR-dependent tumors by disrupting an ARF6-mediated sorting system. Nat Commun 13:6004","journal-title":"Nat Commun"},{"key":"5974_CR25","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.cmet.2023.09.012","volume":"35","author":"AR Terry","year":"2023","unstructured":"Terry AR et al (2023) CD36 maintains lipid homeostasis via selective uptake of monounsaturated fatty acids during matrix detachment and tumor progression. Cell Metab 35:2060\u20132076 e2069","journal-title":"Cell Metab"},{"key":"5974_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41586-018-0287-8","volume":"559","author":"SM Haag","year":"2018","unstructured":"Haag SM et al (2018) Targeting STING with covalent small-molecule inhibitors. Nature 559:269\u2013273","journal-title":"Nature"},{"key":"5974_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26180-4","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang Z et al (2021) DHHC9-mediated GLUT1 s-palmitoylation promotes glioblastoma glycolysis and tumorigenesis. Nat Commun 12:5872","journal-title":"Nat Commun"},{"key":"5974_CR28","doi-asserted-by":"publisher","first-page":"6682","DOI":"10.1038\/s41467-023-42476-z","volume":"14","author":"M Gu","year":"2023","unstructured":"Gu M et al (2023) Palmitoyltransferase DHHC9 and acyl protein thioesterase APT1 modulate renal fibrosis through regulating beta-catenin palmitoylation. Nat Commun 14:6682","journal-title":"Nat Commun"},{"key":"5974_CR29","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1016\/j.molcel.2023.10.043","volume":"83","author":"G Zhang","year":"2023","unstructured":"Zhang G et al (2023) CPT1A induction following epigenetic perturbation promotes MAVS palmitoylation and activation to potentiate antitumor immunity. Mol Cell 83:4370\u20134385e4379","journal-title":"Mol Cell"},{"key":"5974_CR30","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/bjd\/ljad502","volume":"190","author":"AB Mukhtar","year":"2024","unstructured":"Mukhtar AB et al (2024) Targeting CD20-expressing malignant melanoma cells augments BRAF inhibitor killing. Br J Dermatol 190:729\u2013739","journal-title":"Br J Dermatol"},{"key":"5974_CR31","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41388-021-02109-5","volume":"41","author":"Y Shin","year":"2022","unstructured":"Shin Y, Kim S, Ghate NB, Rhie SK, An W (2022) MMP-9 drives the melanomagenic transcription program through histone H3 tail proteolysis. Oncogene 41:560\u2013570","journal-title":"Oncogene"},{"key":"5974_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aax2364","author":"A Kharbanda","year":"2020","unstructured":"Kharbanda A et al (2020) Blocking EGFR palmitoylation suppresses PI3K signaling and mutant KRAS lung tumorigenesis. Sci Signal. https:\/\/doi.org\/10.1126\/scisignal.aax2364","journal-title":"Sci Signal"},{"key":"5974_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41422-018-0124-5","volume":"29","author":"Y Yang","year":"2019","unstructured":"Yang Y et al (2019) Palmitoylation stabilizes PD-L1 to promote breast tumor growth. Cell Res 29:83\u201386","journal-title":"Cell Res"},{"key":"5974_CR34","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.64046","volume":"17","author":"M Qu","year":"2021","unstructured":"Qu M, Zhou X, Wang X, Li H (2021) Lipid-induced S-palmitoylation as a vital regulator of cell signaling and disease development. Int J Biol Sci 17:4223\u20134237","journal-title":"Int J Biol Sci"},{"key":"5974_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41586-018-0466-7","volume":"561","author":"G Eelen","year":"2018","unstructured":"Eelen G et al (2018) Role of glutamine synthetase in angiogenesis beyond glutamine synthesis. Nature 561:63\u201369","journal-title":"Nature"},{"key":"5974_CR36","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201846666","author":"PJ Ko","year":"2018","unstructured":"Ko PJ, Dixon SJ (2018) Protein palmitoylation and cancer. EMBO Rep. https:\/\/doi.org\/10.15252\/embr.201846666","journal-title":"EMBO Rep"},{"key":"5974_CR37","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s11684-021-0911-0","volume":"16","author":"Y Zhang","year":"2022","unstructured":"Zhang Y et al (2022) Palmitoylation of GNAQ\/11 is critical for tumor cell proliferation and survival in GNAQ\/11-mutant uveal melanoma. Front Med 16:784\u2013798","journal-title":"Front Med"},{"key":"5974_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13045-019-0711-z","volume":"12","author":"CY Wei","year":"2019","unstructured":"Wei CY et al (2019) Downregulation of RNF128 activates Wnt\/beta-catenin signaling to induce cellular EMT and stemness via CD44 and CTTN ubiquitination in melanoma. J Hematol Oncol 12:21","journal-title":"J Hematol Oncol"},{"key":"5974_CR39","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cell.2023.11.037","volume":"187","author":"J Pozniak","year":"2024","unstructured":"Pozniak J et al (2024) A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma. Cell 187:166\u2013183e125","journal-title":"Cell"},{"key":"5974_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-016-0502-x","volume":"15","author":"SJ Serrano-Gomez","year":"2016","unstructured":"Serrano-Gomez SJ, Maziveyi M, Alahari SK (2016) Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Mol Cancer 15:18","journal-title":"Mol Cancer"},{"key":"5974_CR41","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/med.21288","volume":"34","author":"M Katoh","year":"2014","unstructured":"Katoh M, Nakagama H (2014) FGF receptors: cancer biology and therapeutics. Med Res Rev 34:280\u2013300","journal-title":"Med Res Rev"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05974-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05974-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05974-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T11:08:26Z","timestamp":1770030506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05974-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5974"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05974-5","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}